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MHChemorrhagic fever that is associated with high morbidity and mortality. The viral
glycoprotein is thought to contribute to pathogenesis, though precise mechanisms are unknown. Cellular
pathogenesis can be modeled in vitro by expression of the Ebola viral glycoprotein (GP) in cells, which causes
dramatic morphological changes, including cell rounding and surface protein down-regulation. These effects
are known to be dependent on the presence of a highly glycosylated region of the glycoprotein, the mucin
domain. Here we show that the mucin domain from the highly pathogenic Zaire subtype of Ebola virus is
sufﬁcient to cause characteristic cytopathology when expressed in the context of a foreign glycoprotein.
Similarly to full length Ebola GP, expression of the mucin domain causes rounding, detachment from the
extracellular matrix, and the down-regulation of cell surface levels of β1 integrin and major histocompat-
ibility complex class 1. These effects were not seen when the mucin domain was expressed in the context of a
glycophosphatidylinositol-anchored isoform of the foreign glycoprotein. In contrast to earlier analysis of full
length Ebola glycoproteins, chimeras carrying the mucin domains from the Zaire and Reston strains appear to
cause similar levels of down-modulation and cell detachment. Cytopathology associated with Ebola
glycoprotein expression does not occur when GP expression is restricted to the endoplasmic reticulum. In
contrast to a previously published report, our results demonstrate that GP-induced surface protein down-
regulation is not mediated through a dynamin-dependent pathway. Overall, these results support a model in
which the mucin domain of Ebola GP acts at the cell surface to induce protein down modulation and
cytopathic effects.
© 2008 Elsevier Inc. All rights reserved.Introduction
Ebola virus is a member of the family Filoviridae, and causes a
severe hemorrhagic fever in humans and non-human primates
(Sanchez et al., 2001). In cell culture, Ebola virus infection causes
pathogenic effects that result in destruction the monolayer (Alazard-
Dany et al., 2006; Barrientos and Rollin, 2007). The speciﬁc
determinants of viral pathogenicity in vivo are still unknown;
however, the viral glycoproteins are thought to play a large role in
cellular pathogenesis (Chan et al., 2000; Volchkov et al., 2001; Yang et
al., 2000). The Ebola virus encodes two forms of its glycoprotein, a
dimeric secreted form (sGP) (Volchkova et al., 1998) and a trimeric
membrane-spanning form, GP, which originates from RNA editing of
the glycoprotein ORF (Sanchez et al., 1996). No cellular toxicity has
been associated with sGP; however, because it is the predominant
form that is transcribed and translated, it is thought that the balance
between sGP and GP may be necessary to control the cytopathic
effects attributed to GP (Volchkov et al., 2001; Yang et al., 2000).When
expressed in vitro and in vivo, GP causes cell rounding, detachment,s).
l rights reserved.and down-regulation of many surface proteins (Simmons et al., 2002;
Takada et al., 2000; Yang et al., 2000). Among the surface proteins
down-modulated by GP are β1 integrin (CD 29), α5 integrin, αV
integrin, and major histocompatibility complex class 1 (MHC1) in
293Tcells (Simmons et al., 2002). However, the exact proﬁle of protein
down-regulation seems to differ by cell type. In primary human
cardiac microvascular endothelial cells GP expression, and the
resultant loss of adhesion, induces anoikis (Ray et al., 2004), whereas
cell lines, such as human 293T, remain viable after cellular detachment
(Simmons et al., 2002).
Analysis of Ebola GP deletion mutants demonstrated that these
morphological changes, along with the down-regulation of surface
proteins, are dependent on a highly O- and N-glycosylated domain
within GP, termed the mucin domain (Simmons et al., 2002; Sullivan
et al., 2005; Takada et al., 2000; Yang et al., 2000). The mucin domain
is approximately 150 amino acids in length and is a conserved feature
of ﬁloviruses, though the primary sequence is highly variable among
subtypes and strains. The domain is thought to have little secondary or
tertiary structure because of its high level of glycosylation. Biochemical
analysis has shown that after cleavage of the glycoprotein precursor by
furin (Volchkov et al., 1998) into GP1 (receptor-recognizing) and GP2
(membrane-spanning) fragments, the N-terminus of GP1 remains
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terminus of GP1 (Sanchez et al., 1998). The mucin domain is not
necessary for GP surface expression or formation of infectious
pseudotyped virions (Manicassamy et al., 2005; Medina et al., 2003;
Yang et al., 2000). There is no single region of the domain that
contributes disproportionately to the rounding phenotype, indicating
that the phenotypemaybedependent on the overall size of thedomain
or level of its glycosylation (Simmons et al., 2002).
Other viruses, such as the Bunyavirus, Crimean Congo Hemor-
rhagic Fever Virus (CCHV) and the polydnavirus, Microplitis demolitor
bracovirus (MdBV), encode proteins with mucin-like domains. While
no rounding or other cytopathology has been reported for the CCHV
mucin-like protein, the MdBV protein Glc1.8 causes rounding when
transfected into insect cells in a manner dependent on membrane
association (Beck and Strand, 2005). In addition, the cellular mucin
protein MUC1 (episialin) has been shown to play a direct role in the
disruption of attachment factors such as β1 integrin when expressed
in melanoma and epithelial cell lines (Wesseling et al., 1995). MUC1 is
known to be highly and aberrantly expressed in many adenocarcino-
mas and its expression correlates with increased metastasis and poor
prognosis (McGuckin et al., 1995; Osako et al., 1993; Yamashita et al.,
1993). MUC1 is thought to interfere with adhesion through steric
hindrance of necessary adhesion molecules (Wesseling et al., 1995). In
addition, it has been shown that the size of the glycosylated region of
MUC1 positively contributes to its ability to interfere with E-cadherin-
based cell–cell interactions (Wesseling et al., 1996). This data agrees
with our previously-published study, which correlated the rounding
phenotype to the size of the Ebola Zaire GP mucin domain (Simmons
et al., 2002).
Although it has been well documented that the presence of the
mucin domain is necessary for GP-mediated cytopathology, it has yet
to be shown that the mucin domain is fully sufﬁcient to induce the
effects discussed above. One report found that murine leukemia virus
amphotropic envelope containing the mucin domain caused an
increase in ﬂoating cells in culture (Yang et al., 2000). Here we
analyzed the requirements for Ebola GP-mediated cytopathology. We
show that themucin domains fromboth the Zaire and Reston subtypes
of the Ebola virus are sufﬁcient to cause morphological alterations
characteristic of GP expression by placing these domains in the context
of a heterologous, monomeric glycoprotein. Using isoforms of this
heterologous protein, we further demonstrate that a membrane-
bound form induces cytopathology, whereas a lipid- (GPI) anchored
isoform does not. Moreover, little is known about the mechanism of
GP-induced cytopathology. Here we show that cytopathology asso-
ciatedwith the expression ofGPdoes not occurwhenGP is restricted to
the endoplasmic reticulum (ER). It has also been reported that the
down-regulation of surface proteins by Ebola GP is likely mediated
through a dynamin-dependent pathway (Sullivan et al., 2005).
However, data reported here support the alternative hypothesis that
this process occurs independently of dynamin.
Results
Characterization of Tva-mucin chimeric constructs
To investigate whether the mucin domain of Ebola GP is sufﬁcient
to cause cell rounding and protein down-regulation, we created
constructs in which the mucin domain was placed into the hetero-
logous, small monomeric glycoprotein, Tva. Tva is an avian glycopro-
tein and is the cellular receptor for subgroup A avian sarcoma and
leukosis virus (ASLV) (Bates et al., 1993). The quail Tva locus also
produces a naturally-occurring splice variant that associates with
membranes through a GPI anchor instead of a transmembrane domain
(P. Bates, unpublished data), termed here, GPI Tva. The mucin domain
from the Zaire subtype of Ebola GP was cloned into vectors expressing
both isoforms of Tva to create expression plasmids for the proteinsdesignated here as Tva-muc and GPI Tva-muc (Fig. 1A). Analysis of
lysates produced from 293T cells transfected with these constructs
demonstrated processing differences among the proteins (Fig.1B). The
multiple bands within each lane represent glycosylation variants of
the proteins while differences between lanes reﬂect the transmem-
brane- versus GPI-anchored forms and the added mucin domain. To
investigate the cellular localization of these proteins, immunoﬂuor-
escence was performed on HeLa cells transfected with each construct
(Fig. 1C). Staining with a polyclonal antibody to a Tva peptide showed
both plasma membrane and cytoplasmic staining of each of the
proteins. Expression of the transmembrane-bound isoforms, Tva and
Tva-muc exhibits a punctuate or vesicular cytoplasmic staining,
whereas GPI Tva and GPI Tva-muc show more of a reticular
cytoplasmic staining pattern. Addition of the mucin domain to either
of the Tva isoforms did not cause any signiﬁcant change in the
observed staining patterns (Fig. 1C).
GP mucin domain is sufﬁcient to cause GP-characteristic cytopathology
To address whether the expression of the chimeric mucin domain
proteins could induce similar morphological changes to those seen
upon expression of Ebola GP, each of the Tva constructs described
above was mixed with an eGFP encoding vector and used to transfect
293T cells. 24 h after transfection, ﬂuorescence microscopy was
performed to visualize transfected cells (Fig. 1D). While transfection of
Tva or GPI Tva did not induce any change in cell morphology, cells
transfected with Tva-muc were rounded and many had lost their
ability to adhere to the extracellular matrix. In contrast, the
transfection of GPI Tva-muc had no effect on cell morphology. To
quantify the mucin domain-induced loss of adhesion to the extra-
cellular matrix, 293T cells were co-transfected with the Tva constructs
and an eCFP-encoding vector. Floating and adherent cells were
removed 24 h post-transfection; only transfected (CFP positive) cells
were counted. Expression of Tva-muc caused cell detachment that
was over ten-fold higher than background levels (Fig. 1E). Transfection
with Tva, GPI Tva, or GPI Tva-muc did not result in cellular detachment
signiﬁcantly above background levels.
To further characterize the effects of the Ebola mucin domain on
cellular physiology, we used ﬂow cytometry to measure surface levels
of β1 integrin andMHC1 in transfected cells. Both of these proteins are
known to be down-regulated from the surface of cells expressing high
levels of Ebola GP (Simmons et al., 2002; Takada et al., 2000). Cells that
were transfected with Tva showed no change in levels of β1 integrin
or MHC1 after 24 h; however, cells transfected with Tva-muc showed
a roughly one log decrease in ﬂuorescence of both proteins (Fig. 2).
Close inspection of the FACS plots reveals that cells with low
expression of Tva-muc have intact levels of β1 integrin and MHC1;
however, there seems to be a threshold of Tva-muc expression, above
which β1 integrin and MHC1 levels drop precipitously. By contrast,
this threshold effect is not seen with GPI Tva-muc. The GPI Tva-muc
sample has expression levels of the chimeric protein that would be
predicted to cause down-regulation of β1 integrin and MHC1, yet this
is not observed. From these results we conclude that the mucin
domain of Ebola GP, when expressed within the context of a
transmembrane-bound form of Tva, is sufﬁcient to cause cytopathol-
ogy characteristic of full-length GP expression.
Reston is considered to be the least pathogenic subtype of Ebola,
while Zaire is the most pathogenic (Fisher-Hoch et al., 1992). Previous
analysis of the glycoproteins from these two Ebola subtypes suggests
that while both glycoproteins cause cytopathic effects, Zaire GP
appears to cause greater levels of cell rounding and surface protein
down modulation (Simmons et al., 2002). To address whether the
isolated mucin domains of different subtypes of Ebola virus differ in
their ability to cause cytopathology, we directly compared chimeric
proteins carrying the mucin regions from Ebola Zaire to Ebola Reston.
The mucin domain of Ebola Reston was expressed within the
Fig. 1. Ebola virus GP-mucin domain is sufﬁcient to induce cell rounding and detachment. (A) Diagram of Tva constructs used to express Ebola Zaire GP-mucin domain. Numbers
indicate amino acid position starting from the initial methionine. (B) 239Tcells were transfectedwith pCAGGS alone (vector) or pCAGGS encoding the Tva constructs described in (A).
Lysates were harvested in RIPA buffer after 24 h and subjected to SDS-4 to 15% PAGE, transferred to PVDF, and immunoblotted with polyclonal rabbit anti-Tva sera or GAPDH-speciﬁc
monoclonal antibodies on blots run in parallel. (C) HeLa cells were transfected with Tva constructs. 48 h posttransfection, cells were ﬁxed, permeabilized, and stained for Tva with
polyclonal rabbit anti-Tva sera followed by Alexa 594 conjugated antibodies. Z-sections were captured on a ﬂuorescence microscope and deconvoluted with software. Images shown
are single, deconvoluted Z-sections. Scale bars are 10.6 μm. (D) 293T cells were co-transfected with Tva constructs and a vector encoding eGFP in a 3:1 ratio. After 24 h ﬂuorescent
images were captured on an inverted microscope using a GFP ﬁlter. Fields represent ﬁndings from multiple experiments. (E) 239T cells were transfected with pCB6 vector alone or
pCB6 encoding the Tva constructs described in (A) and co-transfected with a vector encoding eGFP in a 3:1 ratio. 24 h post-transfection, adherent and non-adherent cells were
removed. CFP positive cells were counted; data is shown as % non-adherent cells. Graph shows mean of 3 replicates; error bars indicate SD. Results are representative of 2
independent experiments.
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revealed that 293T cells transfected with chimeric Tva carrying the
mucin domain from Reston or Zaire subtypes demonstrated similar
levels of surface expression and equal reduction of β1 integrin and
MHC1 surface staining after 24 h (data not shown). In addition,chimeras carrying the Reston mucin domain induced signiﬁcant cell
rounding similar to that observed with the Zaire constructs. Overall,
these results, when compared to previous analyses, suggest that the
ability of themucin domains to induce roundingmay bemodulated by
the context in which they are presented.
Fig. 2. Surface protein down-regulation by Ebola GP-mucin domain. 239T cells were transfected with vector alone or vector encoding the Tva constructs described in Fig. 1A. Floating
and adherent cells were harvested 24 h after transfection, pooled, and stained with polyclonal rabbit anti-Tva sera and FITC-labeled secondary antibodies, co-stained for β1 integrin
or MHC1 with PE-Cy5 conjugated monoclonal antibodies and assayed by ﬂow cytometry. Analysis is shown for events in the live cell gate. (A) β1 integrin vs. Tva surface expression.
(B) MHC1 vs. Tva surface expression. (C) Histogram representation of β1 integrin surface expression (left panels) and MHC1 surface expression (right panels). Control samples are
shown shaded; Tva or GPI Tva is shown as a dashed line; Tva-muc or GPI Tva-muc is shown as a solid line. Data is representative of multiple independent experiments.
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To address whether GP could exert its effects from the endoplasmic
reticulum or if transport to the cell surface is required, we created a
version of the Ebola GP with an ER retention signal, KKMP, appended
to the cytoplasmic tail of the protein (GP-kk). Analysis of lysates madeFig. 3. Ebola virus GP does not round cells when restricted to the ER. (A) 293T cells were tran
harvested in RIPA buffer after 24 h and subjected to SDS-4 to 15% PAGE, transferred to PVDF, a
antibodies. (B) GP and GP-kk lysates were denatured and incubated with enzyme buffer alo
subjected to SDS-PAGE and immunoblotting as described in (A). (C) HeLa cells were transfec
(top row) or permeabilized (middle and bottom rows) and stained for GP with mouse monoc
stained with FITC-conjugated monoclonal antibodies to GM 130 (green) or with rabbit polyc
captured on a ﬂuorescence microscope and deconvoluted. Images shown in top and midd
deconvoluted Z-sections; the merge panel also shows views in the XZ and YZ planes. Scale ba
or GP-kk and co-transfectedwith eGFP in a 3:1 ratio. After 24 h ﬂuorescent imageswere captu
experiments. (E) 293T cells were transfected with vector alone or vector encoding for GP
transfection, adherent and non-adherent cells were removed. CFP positive cells were counte
indicate SD. Results are representative of 2 independent experiments.from 293T cells transfected with GP and GP-kk demonstrated that the
constructs were expressed to a similar level (Fig. 3A). To characterize
the glycosylation state of GP-kk, lysates from GP or GP-kk transfected
cells were incubated with PNGase F, which removes all N-linked
glycans, and Endo Hf, which removes high-mannose glycans,
characteristic of proteins that have not matured through the Golgisfected with vector alone, vector encoding for GP, or GP-kk (ER-restricted). Lysates were
nd immunoblotted with polyclonal rabbit anti-GP sera and GAPDH-speciﬁc monoclonal
ne or buffer with PNGase F or Endoglycosidase Hf (at normal or 3× concentration), then
ted with GP or GP-kk. 48 h posttransfection, cells were ﬁxed, either not permeabilized
lonal antibodies, followed by Alexa 594 conjugated antibodies (red). Cells were also co-
lonal antibodies to calnexin, followed by Alexa 488 antibodies (green). Z-sections were
le rows are composite, deconvoluted Z-sections. Images in the bottom row are single,
rs are 10.6 μm. (D) 293T cells were transfected with vector alone, or vector encoding GP,
red on an invertedmicroscope using a GFP ﬁlter. Fields represent ﬁndings frommultiple
or GP-kk and co-transfected with a vector encoding eGFP in a 3:1 ratio. 24 h post-
d; data is shown as % non-adherent cells. Graph shows mean of 3 replicates; error bars
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Fig. 4. Ebola virus GP does not induce surface protein down-regulation when restricted to ER. 293T cells were transfected with vector alone or vector encoding for GP or GP-kk.
Floating and adherent cells were harvested 24 h after transfection, pooled, and stained with antibodies to GP using human monoclonal antibodies and FITC-labeled secondary
antibodies, co-stained for β1 integrin orMHC1with PE-Cy5 conjugatedmonoclonal antibodies and assayed by ﬂowcytometry. Analysis is shown for events in the live cell gate. (A) β1
integrin vs. GP surface expression. (B) MHC1 vs. GP surface expression. (C) Histogram representation of GP surface expression (left panel), β1 surface expression (middle panel), and
MHC1 surface expression (right panel). Control samples are shown shaded; GP is shown as a solid line, and GP-kk is shown as a dashed line. Data is representative of multiple
independent experiments.
242 J.R. Francica et al. / Virology 383 (2009) 237–247(Fig. 3B). When incubated with Endo Hf, the majority of GP-kk protein
co-migrates with PNGase F digested protein on SDS-PAGE. This Endo
Hf sensitivity suggests that GP-kk is not transported to the Golgi and
remains in the ER. By comparison, the majority of GP is resistant to
Endo Hf digestion, as would be expected of protein that has matured
through the Golgi.
GP cellular localization
To further examine the localization of GP-kk, immunoﬂuorescence
was performed on HeLa cells transfected with GP and GP-kk (Fig. 3C).
Permeabilized and non-permeabilized cells were stained with aFig. 5. GP-mediated surface protein down-regulation is not mediated by dynamin I. (A) 293T
Lysates were harvested in RIPA buffer after 24 h and subjected to SDS-4 to 15% PAGE, transfe
transfected with Dyn K44A. After 22 h, cells were serum starved for 2 h. Cells were then
immediately ﬁxed (T=0), or incubated at 37 °C for 15 min (T=15). Cells were ﬁxed, permeabil
ﬂuorescent microscopy. (C, D) 293T cells were co-transfected (in a 1:3 ratio) with GP and vec
and adherent cells were harvested 24 h after transfection, pooled, and stained with antibod
rabbit anti-Tva sera followed by FITC-labeled secondary antibodies, co-stained for β1 int
cytometry. (E) 239T cells were transfected with GP. After 24 h, ﬂoating cells were either poole
for GP and β1 integrin as described previously. (F) 293T cells were co-transfected with G
permeabilized, and stained for intracellular dynamin I. Shaded peak represents GP+vector-tr
Data is representative of multiple independent experiments.monoclonal antibody to Ebola GP and co-stained with an antibody
to GM-130, a cis-Golgi localized scaffold protein, to test the integrity of
the plasma membrane during staining (Fig. 3C, top and middle
panels). GP-transfected cells displayed intense plasma membrane
staining in both permeabilized and non-permeabilized cells. Some
internal vesicular staining was noted for GP, however this showed no
signiﬁcant colocalization with GM-130 (Fig. 3C, middle panels). By
contrast, only very few non-permeabilized cells transfected with GP-
kk showed any surface staining (data not shown). For the majority of
GP-kk expressing cells, GP staining could only be seen upon
permeabilization (Fig. 3C, bottom panels). Staining of these cells
revealed a cytoplasmic, reticular pattern. GP-kk appeared to co-cells were transfected with vector alone or vector encoding dynamin I K44A (Dyn K44A).
rred to PVDF, and immunoblotted with anti-dynamin I mouse MAb. (B) HeLa cells were
iced and incubated with Alexa 594-conjugated human transferrin. Cells were either
ized, and stained for dynamin I as described in Materials and methods, then analyzed by
tor or GP and Dyn K44A (C), Tva-muc and vector or Tva-muc and Dyn K44A (D). Floating
ies to GP using human monoclonal antibodies and antibodies to Tva using a polyclonal
egrin or MHC1 with PE-Cy5 conjugated monoclonal antibodies, and assayed by ﬂow
d with adherent cells (left plot) or separated from adherent cells (right plot) and stained
P and Dyn K44A (black line) in a 1:3 ratio. Floating cells were harvested after 24 h,
ansfected cells stained for dynamin I. Analyses are shown for events in the live cell gate.
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244 J.R. Francica et al. / Virology 383 (2009) 237–247localize with staining of the ER-resident protein, calnexin, but did not
demonstrate detectable colocalizationwith GM-130 (data not shown).
Thus, we conclude that GP-kk is actively retained in the ER through its
retention signal.
GP-kk does not cause cytopathology
We then asked whether retaining Ebola GP in the ER had any effect
on cell rounding and protein down-regulation. 293T cells were
transfected with GP, GP-kk, or the empty vector and co-transfected
with eGFP as above. 24 h after transfection, microscopy was
performed using a GFP ﬁlter so that only transfected cells were
visualized (Fig. 3D). Cells transfected with the vector were ﬂat and
adherent, whereas GP transfected cells were rounded and ﬂoating.
Cells that had been transfected with GP-kk were morphologically
indistinguishable from the vector control. To quantitate this result,
ﬂoating and adherent cells in culture dishes were counted 24 h after
co-transfection of the GP constructs with an eCFP-encoding vector
(Fig. 3E). The addition of the ER retention signal to GP resulted in a
reduction the number of ﬂoating cells by approximately 98%, to
background levels. 293T cells transfected with GP or GP-kk were
stained with antibodies to Ebola GP and β1 integrin or MHC1 and
analyzed by ﬂow cytometry. Whereas GP strongly down-regulated β1
integrin and MHC1, GP-kk did not (Fig. 4). Flow cytometric analysis of
GP-kk transfected cells, surfaced stained for Ebola GP, reveals that a
small percentage of transfected cells express GP-kk on the surface,
despite the ER retention signal (Fig. 4). This observation is supported
by immunoﬂuorescence studies, where some surface-stained cells are
observed, and also endoglycosidase assay data (Fig. 3B), in which a
small amount of Endo Hf-resistant protein in the GP-kk sample is
visible. Interestingly, in the small amount of cells that show some
surface staining for GP-kk, levels of β1 integrin and MHC1 do not
appear altered. It should also be noted that GP-transfected cells show
down-regulation of GP from the surface resulting in comma-shaped
FACS plots (Figs. 4A, B). However, this comma-shaped proﬁle was not
observed with the Tva constructs (Figs. 2A, B). These data allow us to
conclude that the Ebola GP does not cause morphological changes and
protein down-regulation when retained in the ER.
Surface protein down-regulation is not mediated through a
dynamin-dependent pathway
To address whether surface protein down-regulation was affected
by the expression of a dominant-negative version of dynamin as
previously reported (Sullivan et al., 2005), we employed a construct
expressing human dynamin I with a K44A mutation (Dyn K44A). This
mutation is known to disrupt coated vesicle formation and trafﬁcking
by exerting a dominant negative effect on dynamin's role in vesicle
formation (Damke et al., 1994). Analysis of lysates made from 293T
cells transfected with Dyn K44A demonstrated that the construct was
expressed and that the dynamin I antibody speciﬁcally recognized the
transfected dynamin I protein, not endogenous dynamin II (Fig. 5A). To
examine the ability of Dyn K44A to block vesicle trafﬁcking, a
transferrin uptake assay was performed. As shown in Fig. 5B, labeled
transferrin bound the surface of HeLa cells at 4 °C. When incubated at
37 °C for 15 min, cells internalized the transferrin; however,
transferrin remained at the surface of cells transfected with Dyn
K44A. This effect was also seen after incubation for 30 min; after
60 min the transferrin was mostly degraded (data not shown). Thus,
our Dyn K44A behaves as a functional dominant negative of dynamin-
dependent pathways.
We then addressed whether the expression of Dyn K44A would
alter the level of surface protein down-regulation in GP-transfected
cells. Transfection of Dyn K44A alone did not alter the surface levels of
β1 integrin or MHC1 (data not shown). However, Sullivan et. al.
reported that transfection of dominant negative dynamin reducednearly half of the down-regulation of αV integrin and a signiﬁcant
portion of the down-regulation of MHC1 by GP (Sullivan et al., 2005).
In contrast, we found that after co-transfection of DNA encoding Dyn
K44A and GP in a ratio of 3:1, no change in the down-regulation of
MHC1 or β1 integrin could be observed (Fig 5C). It should be noted
that the transfection efﬁciency of GP in these experiments varied by
less than 2% between samples (Fig 5C, upper left-hand quadrants). We
also examined the effect of Dyn K44A on the down-regulation of β1
integrin andMHC1 by Tva-muc. Transfections were performed as with
GP. Our data indicate that Dyn K44A does not reduce the number of
cells in Tva-muc transfected cultures that have down-regulated levels
of β1 integrin and MHC1 (Fig. 5D).
We have previously reported that in cultures transfected with GP,
ﬂoating cells are 90% positive for GP expression and 95% viable
(Simmons et al., 2002). Here we demonstrate that ﬂoating cells also
exhibited the most dramatic phenotype of surface protein down-
regulation (Fig. 5E). To ensure that cells co-transfected with GP and
Dyn K44A expressed Dyn K44A, ﬂoating cells were also analyzed by
intracellular staining for dynamin I. Flow cytometry revealed that 95%
of ﬂoating cells stained positive for dynamin I (Fig. 5F).
Discussion
The mucin domain of Ebola GP has no apparent critical function in
entry or fusion mediated by the glycoprotein, but instead decreases
binding to target cells and lowers the efﬁciency of infection (Kaletsky
et al., 2007; Manicassamy et al., 2005; Medina et al., 2003). Despite
this fact, there appears to be selective pressure to maintain this
domain and conserve both the overall length and level of glycosylation
suggesting that this portion of the viral glycoprotein plays an
important role in other aspects of the viral infection cycle in vivo.
Within the architecture of the Ebola glycoprotein trimer, the mucin
domain is in a position to interact with other cellular surface proteins
or protect the rest of GP from immune recognition (Lee et al., 2008).
A number of laboratories have observed that expression of Ebola
GP alone can cause cytopathic effects and downmodulation of surface
proteins in numerous types of cultured cells and in isolated blood
vessels (Chan et al., 2000; Simmons et al., 2002; Takada et al., 2000;
Yang et al., 2000). A recent report by Alazard-Dany et al. demonstrated
that similar effects are seen upon infection of cells with Ebola virus.
Analysis of infected cells demonstrated that moderate to low levels of
GP expression seen early in infection do not induce cell rounding; this
is in agreement with our data, which indicates that 293T cells down-
regulate surface proteins after reaching a threshold of surface GP
expression (Figs. 4A, B). However, cell rounding, detachment, and the
down-regulation of β1 integrin and MHC1 can be observed by 48 h
post-infection with Ebola virus, suggesting that the effects seen are
not an artifact of over-expressing GP in vitro (Alazard-Dany et al.,
2006).
The data presented here demonstrate that the mucin domain of
Ebola Zaire is sufﬁcient to cause cytopathic effects that are comparable
with those caused by full-length Ebola GP. Tva-muc induces cell
rounding and detachment in 293T cells and signiﬁcant surface down-
regulation of both β1 integrin and MHC1. Previous studies indicate
that, depending upon cell type, other cell surface proteins can also be
down-regulated by Ebola GP expression (Simmons et al., 2002).
Although not studied here, it seems likely that the isolated mucin
domainwould similarly down-modulate these other cellular proteins.
The extent to which the GP-induced alteration of cellular
morphology and physiology contribute to viral pathogenesis remains
to be tested; however, GP-induced cytopathology may have several
effects. Fatal Ebola infection is characterized by an aberrant innate
immune response with little or no adaptive immune response. This
ineffective immune response permits high rates of Ebola viral
replication in many tissues including liver, spleen, and kidneys
(reviewed in (Zampieri et al., 2007). Non-human primate studies
245J.R. Francica et al. / Virology 383 (2009) 237–247demonstrated that monocytes, macrophage and dendritic cells are
primary targets of Ebola infection (Geisbert et al., 2003a) and have
revealed that the innate immune response and resulting communica-
tion of antigen-presenting cells (APCs) to the adaptive arm of the
immune system is disrupted during Ebola infection (reviewed in
(Mahanty and Bray, 2004). Effects of GP-mediated cytopathology on
APCs could contribute to immune dysregulation. We have previously
demonstrated that GP expression causes rounding in macrophages
(Simmons et al., 2002). Integrins are known to play a critical role in the
homing of leukocytes to sites of infection (Butcher, 1991), therefore
loss of adhesionmay disrupt the function of macrophages or dendritic
cells. Additionally, the down-regulation of MHC1 in other cell types
could be a mechanism of escape from CD8+ T-cell surveillance.
Furthermore, loss of adhesion induced by GP expression in cultured
saphenous veins is thought to be a model for hemorrhagic symptoms
seen during Ebola infection (Sullivan et al., 2005; Yang et al., 2000).
Finally, loss of adhesion by Ebola GP has been shown to cause anoikis
in primary endothelial cells (Ray et al., 2004). GP-induced loss of
adhesion and resulting anoikis could provide one mechanism for
necrosis seen during infection, speciﬁcally in organs such as the liver
where viral replication is high and immune inﬁltration is limited,
though other cellular factors such as tumor necrosis factor-related
apoptosis-inducing ligand have also been implicated in necrotic cell
death (Geisbert et al., 2003a, 2003b).
If the effects of themucin domain contribute to the pathogenesis of
the Zaire subtype of Ebola virus, one might expect cytopathology
caused by the less-pathogenic Reston subtype to be measurably less.
Indeed, our previous report comparing Ebola GP Zaire and Reston
found that GP Reston expression caused not as much cell detachment
and less loss of surface staining of integrins and MHC1 by ﬂow
cytometry (Simmons et al., 2002). In contrast, comparison of chimeric
proteins carrying the isolated mucin domain from either Reston or
Zaire GP indicates that both are equal in their ability to cause
cytopathology. This observationmight indicate that themucin domain
does not determine or signiﬁcantly inﬂuence the pathogenic potential
of Ebola. Alternatively, these ﬁndings may suggest that the presenta-
tion of the mucin domain in the context of the full glycoprotein
regulates the ability of the domain to cause cytopathology.
It is also interesting that, while the mucin domain normally
induces the rounding phenotype from within the GP trimer, we have
demonstrated that it is able to exert these effects from within the
monomeric protein, Tva. When the mucin domain of GP is expressed
in the context of the GPI-anchored isoform of Tva, the rounding
phenotype is abolished and protein down-regulation of MHC1 and β1
integrin is not observed. It is possible that the mucin domain in GPI
Tva-muc is physically positioned or becomes differentially glycosy-
lated in such a way that prevents rounding. A more appealing
alternative is that GPI Tva trafﬁcs or is localized at the plasma
membrane differently than Tva. Immunoﬂuorescence of these con-
structs in HeLa cells shows possible differences in internal staining,
but does not reveal any discernable difference in plasma membrane
staining (Fig. 1C). However, it has been reported that GPI Tva localizes
to detergent-resistant membranes, while Tva does not, and that GPI
Tva trafﬁcs to an acidic compartment through a different endocytic
pathway than Tva upon binding of ASLV (Narayan et al., 2003). These
characteristics could explain the differences between Tva-muc and
GPI Tva-muc.
Themechanism bywhich Ebola GP causes cellular cytopathology is
also unknown. A recent report suggests that GP utilizes a dynamin-
dependent pathway to cause surface protein down-regulation
(Sullivan et al., 2005). Dynamin has been implicated in vesicle ﬁssion
for several pathways, including clathrin-dependent and independent
endocytosis, as well as trans-Golgi budding (Jones et al., 1998; Oh et
al., 1998; van der Bliek et al., 1993). Therefore, it is possible that GP
alters surface protein levels by affecting endocytosis. We addressed
the function of dynamin in the process of GP- and Tva-muc-mediatedsurface protein down-regulation. As demonstrated in Fig. 5, a
dominant negative version of dynamin I effectively blocked endocy-
tosis of the transferrin receptor, but could not block the down-
regulation of β1 integrin or MHC1 by Ebola GP or the chimeric Tva-
muc protein. Thus, we propose a model of down-regulation that is
independent of dynamin-regulated pathways.
The two surface proteins studied here, β1 integrin and MHC1, both
undergo constant endocytosis and recycling back to the plasma
membrane (Bretscher, 1989, 1992; Mahmutefendic et al., 2006; Reid
and Watts, 1990). Many viruses encode proteins that modulate MHC1
levels at the cell surface. For example, the K3 and K5 proteins from
Kaposi's sarcoma-associated herpesvirus increase the rate of MHC1
endocytosis (Coscoy and Ganem, 2000). Other viruses block MHC1
expression by interfering in the ER. The US11 gene encoded by the
human cytomegalovirus retro-translocates newly synthesized MHC1
molecules out of the ER where they are degraded by the proteosome
(Wiertz et al., 1996). Furthermore, some viral proteins are able to
modulate MHC1 levels by inﬂuencing multiple pathways. The Nef
protein from HIV has been reported to increase endocytosis of MHC1
and also to redirect newly-synthesized MHC1 from the trans-Golgi
network (TGN) to the lysosome (Kasper and Collins, 2003; Roeth et al.,
2004; Schwartz et al., 1996). Therefore, it seemed prudent to ask
whether Ebola GP could cause rounding and protein down-regulation
when restricted to the ER. As shown in Fig. 3andFig. 4, our ﬁndings
reject a model of down-regulation of β1 integrin and MHC1 by
interference in the ER. These data suggest a mechanism of regulation
at the plasma membrane or TGN.
GP directs the down-regulation of surface proteins, but also
appears to down-regulate its own surface expression in a manner
that seems concurrent with that of β1 integrin andMHC1 (Figs. 4A, B).
Because themechanism of action is unknown, it is not clear if GP plays
a direct role in guiding the down-regulation of other surface
molecules. It has, however, been reported that GP and αV integrin,
which is also down-regulated in 293T cells, can be co-immunopreci-
pitated (Sullivan et al., 2005). If GP directly binds to proteins to
facilitate down-regulation, this could explain the observation that
cells showing down-modulation of β1 integrin or MHC1 have reduced
surface levels of GP (Fig. 4). Interestingly, Tva-muc is able to down-
regulate β1 integrin and MHC1 without a reduction in surface
expression of Tva-muc (Figs. 2A, B). This could indicate that the
mechanism of down-regulation is indirect, such as through a signaling
cascade which affects endocytosis and/or recycling. Alternatively, it is
possible that Tva-muc interacts directly with β1 integrin and MHC1,
but simply recycles back to the plasma membrane more efﬁciently
than GP. Additional experiments analyzing the mechanism of down-
modulation are required to distinguish these possibilities.
Overall, the data presented here suggests that the mucin domain
within Ebola GP acts at the cell surface to affect cellular adhesion and
down modulate surface protein expression by a mechanism that does
not require dynamin dependent endocytosis. The role of these GP-
mediated effects in the pathogenesis of Ebola virus in primates is
uncertain, however cellular loss of adhesion may play a role cell death
by anoikis, hemorrhagic symptoms, and in combination with reduc-
tion in levels of immune regulatory proteins such as MHC1, likely
contributes to immune evasion by Ebola virus.
Materials and methods
Plasmids, cell culture, and transfections
Tva constructs were created by using two isoforms of the quail Tva
ORF, Tva950 and Tva800 (Bates et al., 1993). The transmembrane
(Tva950) and GPI-anchored (Tva800) isoforms of Tva used here have
the accession numbers L22753 and L22752, respectively. For each
isoform, the mucin domain from the Zaire subtype (Mayinga strain) of
the Ebola virus glycoprotein (amino acids 312–462) or Reston subtype
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At the C-terminal end of themucin domain, a ﬂexible three amino acid
linker, AAV, or PAV was added just before Tva amino acid 78 for the
Zaire and Reston subtypes, respectively. To create an ER-retained
version of Ebola GP, cDNA encoding the membrane-anchored form of
Ebola GP (Mayinga strain, accession number U23187) was used. The
four amino acid tag, KKMP, was appended to the C-terminus of the GP
ORF. Constructs were cloned into the pCAGGS expression vector,
except where indicated. Amino acid positions stated here are counted
from the initial methionine. The dominant negative version of
dynamin I (Dyn K44A) was a gift from Sandra Schmid (Damke et al.,
1994). The coding region for Dyn K44A was removed from its original
vector by EcoRI and XbaI digest and cloned into a pcDNA3.1+ backbone
to create a mammalian expression vector.
All cells were cultured in DMEM (Gibco) with 10% bovine cosmic-
calf serum (HyClone) and penicillin/streptomycin (Gibco) at 37 °Cwith
5% CO2. For ﬂow cytometry, ﬂuorescence microscopy, and western
blotting, 293T cells were plated at ∼8×105 cells per well in 6-well
plates one day prior to transfection. Cells were transiently transfected
by calcium-phosphate precipitation with 6 μg DNA per well unless
otherwise stated. Cells to be visualized with GFP were co-transfected
with an additional 2 μg cDNA encoding eGFP. For enumeration of
ﬂoating cells, 10 cm plates were plated with 4.5×106 293T cells one
day prior to transfection; cells were transiently transfected with 30 μg
DNA encoding GP or Tva constructs and 10 μg DNA encoding eCFP.
Immunoﬂuorescencewas performed using HeLa cells that were plated
on glass coverslips at 6×104 cells per coverslip in 24-well plates one
day prior to transfection. HeLa cells were transiently transfected by
calcium-phosphate precipitationwith 1.5 μg DNA per coverslip. For all
transfections, media were replaced 5 h post-transfection.
Floating cell assay
24 h after transfection, supernatants were removed and combined
with 2 ml PBS that had been used to gently wash the monolayer. An
aliquot of the sample was employed to determine cell concentration
and total sample volume was measured. Only CFP positive cells were
counted using an improved Neubauer hemocytometer (Reichert) on
an Nikon TE300 inverted ﬂuorescent microscope. FACS analysis
demonstrated that N95% of the CFP positive cells also express the
co-transfected GP-encoding plasmid. Percent non-adherent cells were
calculated as: non-adherent cells / (adherent + non-adherent
cells)×100%. All experiments were performed in triplicate.
Cell lysates and western blotting
Transfected cells were removed by resuspension in the culturing
media. Cells were pelleted at 4 °C for 5 min at 1300 ×g. Pellets were
resuspended in RIPA buffer with complete protease inhibitor cocktail
(Roche) for 5minon ice or at roomtemperature. Lysateswere clearedby
centrifugation at 4 °C for 5 min at 20,800 ×g. 30 μl samples were mixed
with reducing SDS buffer, boiled for 5 min, and separated on a 4–15%
Criterion PAGE gel (Bio-Rad). Proteins were transferred to PVDF
(Millipore) at a 400 mA constant current. Membranes were blocked in
5% milk in TBS or 3% BSA in TBST for 45 min or overnight. Membranes
were probedwith rabbit polyclonal anti-GP sera (Lin et al., 2003), rabbit
polyclonal anti-Tva sera (Bates et al., 1993), or mouse anti-dynamin I
MAb (clone 41, BD Transduction Labs) in blocking buffer. Protein was
detectedwith stabilized goat anti-rabbit or anti-mouse HRP conjugated
antibodies (Pierce) in blocking buffer for 45 min. Membranes were
visualized with SuperSignal Femto substrate (Pierce).
Endoglycosidase assay
30 μl of each 293T cell lysate was incubated with denaturing buffer
(NEB) for 10 min at 60 °C. Samples were then incubated with bufferalone (G7 and NP40, NEB), PNGase F, or Endo Hf plus appropriate
buffers (NEB) for 4 to 6 h at 37 °C. Samples were then separated by
SDS-PAGE and blotted as described above.
Transferrin uptake assay
HeLa cells were plated at 1×105 cells per coverslip in a 24-well
plate format. Cells were transfected with Lipofectamine 2000
(Invitrogen) according to manufacturer's instructions with 1.5 μg per
well of Dyn K44A or empty pcDNA3.1 vector. At 22 h post transfection,
media were removed and replaced with DMEM lacking serum. At 24 h
post transfection, cells were placed on ice for 10 min. Human
transferrin conjugated to Alexa Fluor 594 (Invitrogen) was added to
a ﬁnal concentration of 100 μg/ml and incubated on ice for 30 min.
Cells were then washed 3 times with ice-cold PBS and either
immediately ﬁxed (T=0) or incubated with DMEM+10% serum at
37 °C for 15, 30, or 60 min, then ﬁxed. Cells were then stained for
dynamin I as described later.
Flow cytometry
293T cells were detached from the TC plate 24 h post transfection
with PBS −/−, 0.5 mM EDTA and combinedwith well media. Cells were
pelleted at 4 °C for 5 min at 250 ×g, then resuspended in wash buffer
(PBS with 1% bovine calf serum and 0.05% NaAzide) and aliquoted for
staining. For detection of Ebola GP, cells were stained with the human
MAb, KZ52 (Maruyama et al., 1999) and detected with FITC anti-
human IgG (PharMingen). For detection of Tva proteins, cells were
stained with rabbit polyclonal anti-Tva sera (Bates et al., 1993) and
detected with FITC goat anti-rabbit IgG (Rockland). For detection of
β1-integrin, cells were co-stained with anti-human CD29 PE-Cy5
conjugate (eBioscience); for detection of MHC-1, cells were co-stained
with anti- HLA-ABC PE-Cy5 conjugate (eBioscience). For intracellular
dynamin I staining, cells were permeabilized using Cytoﬁx/Cytoperm
(BD Biosciences) for 20 min, followed by washing with Permwash (BD
Biosciences). For detection of dynamin I, cells were stained with
mouse anti-dynamin Mab (clone 41, BD Transduction Labs) and
detected with anti-mouse Alexa Fluor 488 antibodies (Invitrogen) in
Permwash buffer. All staining was performed on ice for 1 h, followed
by washing. Live cell gates were drawn based on forward and side
scatter. For each sample, 10,000 events in the live cell gate were
analyzed. Data were collected on a Becton Dickinson FACSCalibur and
analyzed using FlowJo software (Tree Star, Inc.).
Immunoﬂuorescence
At 48 h post-transfection, media were removed, cells were washed
with PBS, and ﬁxed with 3% PFA in PBS for 20 min. Cells were then
washed with PBS, then permeabilized with 0.2% saponin, 1% goat
serum in PBS for 5 min, then washed with PBS. Cells were blocked
with 10% goat serum, 0.1% Tween-20 in PBS for 2 h. For GP and ER
staining, coverslips were incubated with mouse anti-Ebola GP MAb
(gift from Yoshihiro Kawaoka) and rabbit anti-calnexin (StressGen)
and detected with goat anti-mouse or rabbit Alexa Fluor 594 or 488
antibodies, respectively (Invitrogen). For Golgi staining, cells were re-
blocked with 10%mouse sera, then probed withmouseMAb FITC anti-
GM 130 (BD Transduction Labs). For Tva staining, coverslips were
incubated with rabbit polyclonal anti-Tva sera and detected with anti-
rabbit Alexa Fluor 594 antibodies (Invitrogen). For dynamin I staining,
coverslips were incubated with mouse anti-dynamin I MAb (clone 41,
BD Transduction Labs) and detected with anti-mouse Alexa Fluor 488
antibodies (Invitrogen). Cells were washed with PBS after each
staining step. For non-permeabilizing conditions, cells were ﬁxed
with 1% PFA in PBS for 20 min, washed, then blocked with 10% goat
serum in PBS and stained as described above. All coverslips were
mounted on glass slides with mounting medium containing DAPI
247J.R. Francica et al. / Virology 383 (2009) 237–247(Vectasheild). Z-section images were collected on a Leica DMRE
ﬂuorescence microscope using Open Lab software (Improvision).
Thirty Z-sections per image were collected at 0.2 μm intervals. Z-
section datawere deconvoluted using Velocity software (Improvision)
to a 98% conﬁdence level or 15 iterations. Images shown are single,
deconvoluted, Z-sections except where indicated.
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